Zinc therapy in dermatology: a review

Mrinal Gupta, Vikram K Mahajan, Karaninder S Mehta, Pushpinder S Chauhan, Mrinal Gupta, Vikram K Mahajan, Karaninder S Mehta, Pushpinder S Chauhan

Abstract

Zinc, both in elemental or in its salt forms, has been used as a therapeutic modality for centuries. Topical preparations like zinc oxide, calamine, or zinc pyrithione have been in use as photoprotecting, soothing agents or as active ingredient of antidandruff shampoos. Its use has expanded manifold over the years for a number of dermatological conditions including infections (leishmaniasis, warts), inflammatory dermatoses (acne vulgaris, rosacea), pigmentary disorders (melasma), and neoplasias (basal cell carcinoma). Although the role of oral zinc is well-established in human zinc deficiency syndromes including acrodermatitis enteropathica, it is only in recent years that importance of zinc as a micronutrient essential for infant growth and development has been recognized. The paper reviews various dermatological uses of zinc.

References

    1. Nitzan YB, Cohen AD. Zinc in skin pathology and care. Journal of Dermatological Treatment. 2006;17(4):205–210.
    1. Kitamura H, Morikawa H, Kamon H, et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nature Immunology. 2006;7(9):971–977.
    1. Brocard A, Knol A, Khammari A, Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach—a pilot study. Dermatology. 2007;214(4):325–327.
    1. Sharma NL. Zinc, an update. Indian Journal of Dermatology, Venereology and Leprology. 1985;51:305–308.
    1. Bangash HK, Sethi A. Handbook of Diet, Nutrition and the Skin. Vol. 2. Wageningen Academic; 2012. Zinc and skin health: an overview; pp. 178–195. (Human Health Handbooks no. 1).
    1. Sharquie KE, Khorsheed AA, Al-Nuaimy AA. Topical zinc sulphate solution for treatment of viral warts. Saudi Medical Journal. 2007;28(9):1418–1421.
    1. Khattar JA, Musharrafieh UM, Tamim H, Hamadeh GN. Topical zinc oxide vs salicylic acid-lactic acid combination in the treatment of warts. International Journal of Dermatology. 2007;46(4):427–430.
    1. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. British Journal of Dermatology. 2002;146(3):423–431.
    1. Mun JH, Kim SH, Jung DS, et al. Oral zinc sulfate treatment for viral warts: an open-label study. Journal of Dermatology. 2011;38:541–545.
    1. Sharma S, Barman KD, Sarkar R, Manjhi M, Garg VK. Efficacy of oral zinc therapy in epidermodysplasia verruciformis with squamous cell carcinoma. Indian Dermatology. 2014;5:55–58.
    1. Sharquine KA, Al-Nuaimy AA. Treatment of viral warts by intralesional injection of zinc sulphate. Annals of Saudi Medicine. 2002;22(1-2):26–28.
    1. Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology. 2004;209(1):46–49.
    1. Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clinical and Experimental Dermatology. 2001;26(1):21–26.
    1. Gupta A, Sharma VK, Vohra H, Ganguly NK. Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients. FEMS Immunology and Medical Microbiology. 1999;24:49–55.
    1. Mathur NK, Bumb RA, Mangal HN. Oral zinc in recurrent erythema nodosum leprosum reaction. Leprosy In India. 1983;55(3):547–552.
    1. Mathur NK, Bumb RA, Mangal HN, Sharma ML. Oral zinc as an adjunct to dapsone in lepromatous leprosy. International Journal of Leprosy. 1984;52(3):331–338.
    1. Fernández-Romero JA, Abraham CJ, Rodriguez A, et al. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrobial Agents and Chemotherapy. 2012;56(1):358–368.
    1. Mahajan BB, Dhawan M, Singh R. Herpes genitalis—topical an alternative therapeutic modality. Indian Journal of Sexually Transmitted Diseases. 2013;34:32–34.
    1. Chretien JH, Esswein JG, Sharpe LM, Kiely JJ, Lyddon FE. Efficacy of undecylenic acid-zinc undecylenate powder in culture positive tinea pedis. International Journal of Dermatology. 1980;19(1):51–54.
    1. Scribner MD. Zinc sulfate and axillary perspiration odor. Archives of Dermatology. 1977;113(9, article 1302)
    1. Sharquie KE, Noaimi AA, Hameed SD. Topical 15% zinc sulfate solution is an effective therapy for feet odor. Journal of Cosmetics, Dermatological Sciences and Applications. 2013;3:203–208.
    1. Sharquie KE, Al-Dori WS, Sharquie IK, Al-Nuaimy AA. Treatment of pityriasis versicolor with topical 15% zinc sulfate solution. Iraqi Journalof Community Medicine. 2008;21:61–63.
    1. Michaelsson G. Zinc therapy in acrodermatitis enteropathica. Acta Dermato—Venereologica. 1974;54(5):377–381.
    1. Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135–140.
    1. Hillström L, Pettersson L, Hellbe L, Kjellin A, Leczinsky CG, Nordwall C. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. British Journal of Dermatology. 1977;97(6):681–684.
    1. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Dermato-Venereologica. 1978;58(5):443–448.
    1. Verma K, Saini A, Dhamija S. Oral zinc sulfate therapy in acne vulgaris: a double-blind trial. Acta Dermato-Venereologica. 1980;60(4):337–340.
    1. Lidén S, Göransson K, Odsell L. Clinical evaluation in acne. Acta Dermato—Venereologica. 1980;89:47–52.
    1. Cochran RJ, Tucker SB, Flannigan SA. Topical zinc therapy for acne vulgaris. International Journal of Dermatology. 1985;24(3):188–190.
    1. Feucht CL, Allen BS, Chalker DK, Smith JG., Jr. Topical erythromycin with zinc in acne. A double-blind controlled study. Journal of the American Academy of Dermatology. 1980;3(5):483–491.
    1. Habbema L, Koopmans B, Menke HE, Doornweerd S, De Boulle K. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. British Journal of Dermatology. 1989;121(4):497–502.
    1. Schachner L, Eaglstein W, Kittles C, Mertz P. Topical erythromycin and zinc therapy for acne. Journal of the American Academy of Dermatology. 1990;22(2, part 1):253–260.
    1. Schachner L, Pestana A, Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. Journal of the American Academy of Dermatology. 1990;22(3):489–495.
    1. Sharquie KE, Noaimi AA, Al-Salih MM. Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution. Saudi Medical Journal. 2008;29(12):1757–1761.
    1. van Hoogdalem EJ, Terpstm IJ, Baven ALM. Evaluation of the effect of zinc acetate on the stratum corneum penetration kinetics of erythromycin in healthy male volunteers. Skin Pharmacology. 1996;9(2):104–110.
    1. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. Journal of the European Academy of Dermatology and Venereology. 2007;21(3):311–319.
    1. Bae YS, Hill ND, Bibi Y, Dreiher J, Cohen AD. Innovative uses for zinc in dermatology. Dermatologic Clinics. 2010;28(3):587–597.
    1. Orris L, Shalita AR, Sibulkin D, London SJ, Gans EH. Oral zinc therapy of acne. Absorption and clinical effect. Archives of Dermatology. 1978;114(7):1018–1020.
    1. Weimar VM, Puhl SC, Smith WH, TenBroeke JE. Zinc sulfate in acne vulgaris. Archives of Dermatology. 1978;114(12):1776–1778.
    1. Cunliffe WJ. Unacceptable side-effects of oral zinc sulphate in the treatment of acne vulgaris. British Journal of Dermatology. 1979;101, article 363
    1. Dreno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Dermato-Venereologica. 1989;69(6):541–543.
    1. Dréno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135–140.
    1. Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. European Journal of Dermatology. 2000;10(4):269–273.
    1. Michaelsson G, Juhlin L, Ljunghall K. A double blind study of the effect of zinc and oxytetracycline in acne vulgaris. British Journal of Dermatology. 1977;97(5):561–566.
    1. Sardana K, Garg VK. An observational study of methionine-bound antioxidants for mild to moderate vulgaris. Dermatology and Therapy. 2010;23:411–418.
    1. James KA, Burkhart CN, Morrell DS. Emerging drugs for acne. Expert Opinion on Emerging Drugs. 2009;14(4):649–659.
    1. Pierard-Franchimont C, Goffin V, Visser JN, Jacoby H, Pierard GE. A double blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex. European Journal of Clinical Pharmacology. 1995;49(1-2):57–60.
    1. Sharquie KE, Najim RA, Al-Salman HN. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. International Journal of Dermatology. 2006;45(7):857–861.
    1. Bamford JT, Gessert CE, Haller IV, Kruger K, Johnson BP. Randomized, double-blind trial of 220mg zinc sulfate twice daily in the treatment of rosacea. International Journal of Dermatology. 2012;51:459–462.
    1. Brocard A, Knol AC, Khammari A, Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214(4):325–327.
    1. Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobata with oral zinc. British Journal of Dermatology. 1999;141(6):1137–1138.
    1. Sadeghian G, Ziaei H, Nilforoushzadeh MA. Treatment of localized psoriasis with a topical formulation of zinc pyrithione. Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 2011;20(4):187–190.
    1. Clemmensen OJ, Siggaard-Andersen J, Worm AM, Stahl D, Frost F, Bloch I. Psoriatic arthritis treated with oral zinc sulphate. British Journal of Dermatology. 1980;103(4):411–415.
    1. Burrows NP, Turnbull AJ, Punchard NA, Thompson RPH, Jones RR. A trial of oral zinc supplementation in psoriasis. Cutis. 1994;54(2):117–118.
    1. Landsdown ABG. Zinc in the healing wound. The Lancet. 1996;347(9003):706–707.
    1. Baldwin S, Odio MR, Haines SL, O'Connor RJ, Englehart JS, Lane AT. Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper. Journal of the European Academy of Dermatology and Venereology. 2001;15(supplement 1):5–11.
    1. Faghihi G, Iraji F, Shahingohar A, Saidat AH. The efficacy of “0.05% Clobetasol + 2.5% zinc sulphate” cream versus “0.05% Clobetasol alone” cream in the treatment of the chronic hand eczema: a double-blind study. Journal of the European Academy of Dermatology and Venereology. 2008;22(5):531–536.
    1. Wiegand C, Hipler UC, Boldt S, Strehle J, Wollina U. Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis. Clinical, Cosmetic and Investigational Dermatology. 2013;6:115–121.
    1. Wilkinson EAJ. Oral zinc for arterial and venous leg ulcers. Cochrane Database of Systematic Reviews. 2012;8CD001273
    1. Strömberg HE, Ågren MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. British Journal of Dermatology. 1984;111:461–468.
    1. Cornwall MC. Zinc iontophoresis to treat ischemic skin ulcers. Physical Therapy. 1981;61(3):359–360.
    1. Sehgal VN, Prasad PVS, Kaviarasan PK, Rajan D. Trophic skin ulceration in leprosy: evaluation of the efficacy of topical phenytoin sodium zinc oxide paste. International Journal of Dermatology. 2014;53(7):873–878.
    1. Wilkinson EAJ, Hawke CI. Does oral zinc aid the healing of chronic leg ulcers? A systematic literature review. Archives of Dermatology. 1998;134(12):1556–1560.
    1. Sharquie KE, Najim RA, Al-Dori WS, Al-Hayani RK. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study. Journal of Dermatology. 2006;33(8):541–546.
    1. Sharquie KE, Najim RA, Al-Hayani RK, Al-Nuaimy AA, Maroof DM. The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone. Saudi Medical Journal. 2008;29(5):734–738.
    1. Sinclair SA, Reynolds NJ. Necrolytic migratory erythema and zinc deficiency. The British Journal of Dermatology. 1997;136(5):783–785.
    1. Patel U, Loyd A, Patel R, Meehan S, Kundu R. Necrolytic acral erythema. Dermatology. 2010;16(11):p. 15.
    1. Berger RS, Fu JL, Smiles KA, et al. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. British Journal of Dermatology. 2003;149(2):354–362.
    1. Sharquie KE, Noaimi AA, Shwail ER. Oral zinc sulphate in treatment of alopecia areata. Journal of Clinical and Experimental Dermatology Research. 2012;3:p. 150.
    1. Ikeda M, Arata J, Isaka H. Erosive pustular dermatosis of the scalp successfully treated with oral zinc sulphate. British Journal of Dermatology. 1982;106(6):742–743.
    1. Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. British Journal of Dermatology. 1985;112(4):415–422.
    1. Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacology and Applied Skin Physiology. 2002;15(6):434–441.
    1. Mehdipour M, Taghavi Zenouz A, Bahramian A, Yazdani J, Pouralibaba F, Sadr K. Comparison of the effect of mouthwashes with and without fluocinolone on the healing process of erosive oral planus. Journal of Dental Research, Dental Clinics, Dental Prospects. 2010;4:25–28.
    1. Sharquie KE, Noaimi AA, Kadir NO. Topical therapy of xeroderma pigmentosa with 20% zinc sulfate solution. Iraqi Journal of Postgraduate Medicine. 2008;7:231–237.
    1. Sharquie KE, Al-Mashhadani SA, Noaimi AA, Hasan AA. Topical zinc sulphate (25%) solution: a new therapy for actinic keratosis. Journal of Cutaneous and Aesthetic Surgery. 2012;5:p. 53.
    1. Sharquie KE, Al-Nuaimy AA, Al-Shimary FA. New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution. Saudi Medical Journal. 2005;26(2):359–361.
    1. Shameer P, Prasad PVS, Kaviarasan PK. Serum zinc level in vitiligo: a case control study. Indian Journal of Dermatology, Venereology and Leprology. 2005;71(3):206–207.
    1. Bagherani N, Yaghoobi R, Omidian M. Hypothesis: Zinc can be effective in treatment of vitiligo. Indian Journal of Dermatology. 2011;56(5):480–484.
    1. Yaghoobi R, Omidian M, Bagherani N. Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial. BMC Dermatology. 2011;11, article 7
    1. Sharquie KE, Al-Mashhadani SA, Salman HA. Topical 10% zinc sulfate solution for treatment of melasma. Dermatologic Surgery. 2008;34(10):1346–1349.
    1. Yousefi A, Khani Khoozani Z, Zakerzadeh Forooshani S, Omrani N, Moini AM, Eskandari Y. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study. Dermatologic Surgery. 2014;40(1):33–37.
    1. Iraji F, Tagmirriahi N, Gavidnia K. Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma. Advanced Biomedical Research. 2012;1, article 39
    1. Söderberg T, Hallmans G, Bartholdson L. Treatment of keloids and hypertrophic scars with adhesive zinc tape. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 1982;16(3):261–266.
    1. Moshref S. Topical zinc oxide adhesive tape for keloid management. The Egyptian Journal of Surgery. 2006;25:169–177.
    1. Mahoney MG, Brennan D, Starcher B, et al. Extracellular matrix in cutaneous ageing: the effects of 0.1% copper-zinc malonate-containing cream on elastin biosynthesis. Experimental Dermatology. 2009;18(3):205–211.
    1. Marone G, Columbo M, de Paulis A, Cirillo R, Giugliano R, Condorelli M. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells. Agents and Actions. 1986;18(1-2):103–106.
    1. Pinnell SR, Fairhurst D, Gillies R, Mitchnick MA, Kollias N. Microfine zinc oxide is a superior sunscreen ingredient to microfine titanium dioxide. Dermatologic Surgery. 2000;26(4):309–314.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe